This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Abbott Labs' Beats on Adjusted Basis Despite Drop in Net Income

NEW YORK (TheStreet) -- Abbott Laboratories  (ABT) reported on Wednesday first-quarter net income that fell 31%, but adjusted earnings still managed to beat expectations.

VIDEO TRANSCRIPT:

Shares of Abbott Laboratories are climbing slightly higher on Wednesday after the company reported first-quarter net income that fell 31%, but adjusted earnings still managed to beat expectations.

Abbott said it earned $375 million, or 24 cents a share in the quarter, down from $544 million, or 34 cents a share, a year ago.  Excluding items, Abbott earned 41 cents a share, topping analyst expectations of 36 cents a share, according to Thomson Reuters.

The company's diagnostic and laboratory test unit saw sales gains of 2.6% during the period, and was Abbott's only unit to post increases.  Abbott's results were weighed down by a negative impact of foreign exchange rates as well as the shutdown of a drug manufacturing plant.

WATCH: More market update videos on TheStreet TV | More videos from Brittany Umar

Looking forward, the company reaffirmed its full-year 2014 earnings forecast, expecting $2.16 to $2.26 a share.

In New York, I'm Brittany Umar for TheStreet.

-- Written by Brittany Umar in New York.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $130.28 0.47%
FB $81.53 -1.07%
GOOG $565.06 3.30%
TSLA $218.42 -0.08%
YHOO $44.52 1.89%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs